Showing posts with label diajapan. Show all posts
Showing posts with label diajapan. Show all posts

Thursday, September 27, 2012

Importance of Development Strategies for Life Cycle Management of Safe and Effective Medical Products - 9th DIA Japan Annual Meeting


 
 
9th DIA Japan Annual Meeting | Importance of Development Strategies for Life Cycle Management of Safe and Effective Medical Products | November
19-21, 2012 | Tokyo, Japan
News & PublicationsMeetings & TrainingsSpeaking & PublishingNetworking
& CommunitiesExhibiting AdvertisingCareer Center
9th DIA Japan Annual Meeting Program
Now Available!
Prepare for Japan’s Annual Meeting by choosing what events and sessions you would like to attend. Informative tutorials, outstanding speakers, excellent presenters, interactive sessions and exciting network opportunities await you!
 
3 days of interacting with biopharmaceutical industry, contract service organizations, regulatory agencies, health ministries, patient organizations, universities and students from throughout Japan and worldwide. Plus, attend the DIA Awards Presentation, with presenter and DIA Board President Ling Su, PhD.
 
Program now available here!
       
Register today for the early bird special until October 29!
UPCOMING EVENTS
Clinical Forum | The Hague 2012 | The Empowered Patient | 8-10 October 2012 | The Hague, The Netherlands
Tutorials and Keynote Speeches
Tutorials:
Tutorial 1: Company Core Data Sheets Prepared by Western Companies
Tutorial 2: Roundtable Discussion: What are Preferable Skill Sets in Clinical Development
Tutorial 3: Group Work: Action Learning for Six Sig
Tutorial 4: Risk Management Plan - Standard (As of 10/30/2012)
Tutorial 5: Leadership and Philosophy: Best Practice
Tutorial 6: Basic Understanding of Bioequivalence
 
Don’t Miss the Keynote Speeches!
Keynote Speaker 1: Peter Bachmann, DrSc
European and International Affairs Member of the CMDh
(Co-ordination Group for Mutual Recognition and
Decentralised Procedures - Human) on the Latest Regulatory Environment in EU - from Development to Post-Marketing.

Keynote Speech 2: Takao Yamori, PhD
Director of Center for Product Evaluation, Pharmaceuticals and Medical Devices Agency (PMDA) to discuss the New Drug Development of Japan Origin through Industry-Academia Collaboration.
 FacebookLinkedInTwitterYouTube
 

一般社団法人ディー・アイ・エー・ジャパン
106-0041 東京都港区麻布台1-11-10
Tel. +03-5575-2130
Fax. +03-3583-1200
email: diajapan@diajapan.org

Monday, August 13, 2012

CALL FOR ABSTRCTS: 16th Annual Workshop in Japan for Clinical Data Management: SMART CDM ends 8/25

Meeting Date:
2/7/2013 8:30:00 AM - 2/8/2013 5:00:00 PM       
Location:
Tower Hall Funabori 4-1-1 Funabori Edogawa-ku Tokyo 134-0091 Japan       
Overview:
It’s the 16th DIA Clinical Data Management workshop in Japan. As the international meeting for professionals, we encourage all levels, from beginners to experts, to participate this annual meeting. And we hope to provide a more sophisticated program. Changes in the world are very fast. Especially ‘Information’ and ‘Technology’ are growing to be complex, globalize, and mass. However, we can hear the word ‘smart’ here and there recently. Because people don’t hope to be swayed by them, people hope to take advantage of them. We think that the environment surrounding the CDM is similar to this. Therefore the theme was determined to “SMART CDM”. Because we would like to consider with you how we can be a smart CDM. This workshop is expected to form a sessions on the following topics.
  • Standardization, Safety, Speedy, Strategy, Simplification
  • Management, Metrics, Metadata, Multinational
  • Assurance, Asia, Adaptive design, Accuracy
  • Risk based approach, Regulation, Reliability, Relationship
  • Technology, Teamwork, Terminology, Translate
Objectives of this workshop are to improve the quality of clinical research and data management activities. This annual workshop will provide information to attendees about the international clinical data management, and attendees will get opportunities to network with colleagues in global Clinical Data Management.

Target Audience:
  • Clinical data managers
  • Clinical research coordinators
  • Biostatisticians
  • Clinical development professionals
  • Information technology professionals
  • QC/QA professionals
  • Regulatory affairs professionals

Continue Abstract Submission